Related Experiment Video
Updated: Jul 17, 2026

Quantification of Coenzyme A in Cells and Tissues
Published on: September 27, 2019
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine
Roberta Leonardi1, Charles O Rock, Suzanne Jackowski
1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
The human isoform 2 of pantothenate kinase (PanK2) is localized to the mitochondria, and mutations in this protein are associated with a progressive neurodegenerative disorder. PanK2 inhibition by acetyl-CoA is so stringent (IC50 < 1 microM) that it is unclear how the enzyme functions in the presence of intracellular CoA concentrations. Palmitoylcarnitine was discovered to be a potent activator of PanK2 that functions to competitively antagonize acetyl-CoA inhibition. Acetyl-CoA was a competitive inhibitor of purified PanK2 with respect to ATP. The interaction between PanK2 and acetyl-CoA was stable enough that a significant proportion of the purified protein was isolated as the PanK2.acetyl-CoA complex. The long-chain acylcarnitine activation of PanK2 explains how PanK2 functions in vivo, by providing a positive regulatory mechanism to counteract the negative regulation of PanK2 activity by acetyl-CoA. Our results suggest that PanK2 is located in the mitochondria to sense the levels of palmitoylcarnitine and up-regulate CoA biosynthesis in response to an increased mitochondrial demand for the cofactor to support beta-oxidation.
Insights
Pantothenate kinase 2 (PanK2) is activated by palmitoylcarnitine, overcoming acetyl-CoA inhibition. This mitochondrial enzyme regulates Coenzyme A biosynthesis, crucial for energy production and preventing neurodegeneration.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Pantothenate kinase (PanK2) is a mitochondrial enzyme.
- Mutations in PanK2 cause progressive neurodegenerative disorders.
- PanK2 is potently inhibited by acetyl-CoA, raising questions about its in vivo function.
Purpose of the Study:
- To elucidate the regulatory mechanism of human PanK2.
- To understand how PanK2 functions despite strong acetyl-CoA inhibition.
- To investigate the role of PanK2 in mitochondrial Coenzyme A biosynthesis.
Main Methods:
- Enzyme kinetics studies with purified PanK2.
- Investigated the effects of acetyl-CoA and palmitoylcarnitine on PanK2 activity.
- Characterized the interaction between PanK2 and acetyl-CoA.
Main Results:
- Palmitoylcarnitine is a potent activator of PanK2, competitively antagonizing acetyl-CoA inhibition.
- Acetyl-CoA competitively inhibits PanK2 with respect to ATP.
- A stable PanK2.acetyl-CoA complex was isolated, indicating a strong interaction.
Conclusions:
- Long-chain acylcarnitine activation explains PanK2's in vivo function by counteracting acetyl-CoA inhibition.
- Mitochondrial localization allows PanK2 to sense palmitoylcarnitine levels.
- PanK2 up-regulates Coenzyme A biosynthesis in response to mitochondrial demand, supporting beta-oxidation.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
The ADP/ATP Carrier Protein
PI3K/mTOR/AKT Signaling Pathway
ATP Synthase: Mechanism
